Bayer to invest $2.2B in New Albany plant

Bayer plans to invest $2.2 billion in a new pharmaceutical manufacturing plant in New Albany, Ohio, marking its first processing and manufacturing operation in North America. The facility will create approximately 1,500 construction jobs and 600 full-time positions, producing drug components for therapies such as oncology and cardiovascular treatments. Construction is expected to begin mid-2027, with production starting by 2031, supported by state incentives and workforce training initiatives.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل